A Phase II trial to assess the efficacy and safety ofpasireotide s.c. alone or in combination with cabergoline inpatients with Cushing’s disease A Phase II trial to assess the efficacy and safety ofpasireotide s.c. alone or in combination with c ...
A Phase II trial to assess the efficacy and safety ofpasireotide s.c. alone or in combination with cabergoline inpatients with Cushing’s disease A Phase II trial to assess the efficacy and safety ofpasireotide s.c. alone or in combination with c ...